MarketCap
Facebook
X
TelegramAnnual report 2024
added 12-27-2025
Country |
 Israel |
IPO year |
2015 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ CAPITAL |
Shares |
5.85 M |
Market Cap[1] |
$ 9.42 M |
EBITDA (LTM) |
$ -13.1 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
1.29 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market |  USA |
 |
Brainsway Ltd.
BWAY
|
$ 18.71 | -3.41 % | $ 99.4 M | Nasdaq Global Select Market | Israel |
 |
Burning Rock Biotech Limited
BNR
|
$ 20.72 | -2.15 % | $ 223 M | Nasdaq Global Market |  China |
 |
Co-Diagnostics
CODX
|
$ 0.23 | -1.28 % | $ 6.75 M | Nasdaq Capital Market | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
Castle Biosciences
CSTL
|
$ 39.08 | -0.8 % | $ 1.09 B | Nasdaq Global Market,SPB | USA |
 |
Danaher Corporation
DHR
|
$ 230.45 | 0.06 % | $ 168 B | NYSE,SPB | USA |
 |
BioNano Genomics
BNGO
|
$ 1.5 | -1.28 % | $ 1.91 M | Nasdaq Capital Market,SPB | USA |
 |
DarioHealth Corp.
DRIO
|
$ 10.65 | 6.03 % | $ 302 M | Nasdaq Capital Market | Israel |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
Exact Sciences Corporation
EXAS
|
$ 101.57 | - | $ 18.8 B | Nasdaq Capital Market,SPB | USA |
 |
DexCom
DXCM
|
$ 67.66 | 0.13 % | $ 26.1 B | Nasdaq Global Select Market,SPB | USA |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Fulgent Genetics
FLGT
|
$ 26.45 | -1.01 % | $ 800 M | Nasdaq Global Market | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | China |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
CareDx, Inc
CDNA
|
$ 19.01 | -2.41 % | $ 1.02 B | Nasdaq Global Market,SPB | USA |
 |
Celcuity
CELC
|
$ 101.35 | -0.88 % | $ 4 B | Nasdaq Global Select Market | USA |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
Anixa Biosciences
ANIX
|
$ 3.17 | -0.83 % | $ 101 K | Nasdaq Capital Market | USA |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
IQVIA Holdings
IQV
|
$ 226.47 | -0.2 % | $ 41.1 B | NYSE,SPB | USA |
 |
Guardant Health
GH
|
$ 101.35 | -1.59 % | $ 12.4 B | Nasdaq Global Select Market,SPB | USA |
 |
Myriad Genetics
MYGN
|
$ 6.32 | -2.41 % | $ 573 M | Nasdaq Global Select Market,SPB | USA |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
ENDRA Life Sciences
NDRA
|
$ 4.95 | -2.6 % | $ 2.66 M | Nasdaq Global Select Market | USA |
 |
Neogen Corporation
NEOG
|
$ 7.17 | 0.56 % | $ 1.56 B | Nasdaq Global Select Market,SPB | USA |
 |
National Research Corporation
NRC
|
$ 18.83 | 0.88 % | $ 462 M | Nasdaq Global Select Market | USA |
 |
Koninklijke Philips N.V.
PHG
|
$ 27.21 | 0.37 % | $ 20 B | NYSE |  Niderland |
 |
Illumina
ILMN
|
$ 133.18 | -1.32 % | $ 21.2 B | Nasdaq Global Select Market,SPB | USA |
 |
Charles River Laboratories International
CRL
|
$ 202.55 | -0.55 % | $ 10.4 B | NYSE,SPB | USA |
 |
Personalis
PSNL
|
$ 8.01 | -1.6 % | $ 475 M | Nasdaq Global Select Market | USA |
 |
Quidel Corporation
QDEL
|
$ 29.09 | -0.72 % | $ 1.23 B | Nasdaq Global Select Market,SPB | USA |
 |
RadNet
RDNT
|
$ 73.13 | -0.03 % | $ 5.34 B | Nasdaq Global Select Market | USA |
 |
Soleno Therapeutics
SLNO
|
$ 47.69 | 0.08 % | $ 1.92 B | Nasdaq Capital Market | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 174.88 | -0.6 % | $ 19.4 B | NYSE,SPB | USA |
|
Biodesix
BDSX
|
$ 6.65 | -2.57 % | $ 862 M | Nasdaq Global Market | USA |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | Israel |
 |
Laboratory Corporation of America Holdings
LH
|
$ 252.38 | -0.59 % | $ 21.2 B | NYSE,SPB | USA |
 |
ICON Public Limited Company
ICLR
|
$ 182.35 | -0.27 % | $ 15 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
$ 682.6 | -0.85 % | $ 56.3 B | Nasdaq Global Select Market,SPB | USA |
 |
Lantheus Holdings
LNTH
|
$ 66.84 | 0.19 % | $ 4.63 B | Nasdaq Global Select Market,SPB | USA |
 |
Mettler-Toledo International
MTD
|
$ 1 407.81 | -0.87 % | $ 29.9 B | NYSE,SPB |  Schweiz |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.